Some assays and procedures require a surface that is nonbinding because many
proteins, enzymes in particular, may become activated or inactivated upon
attachment to a surface. Corning's unique NBS treatment (U.S. Patents
6,093,559 and 6,319,664) creates a nonionic hydrophilic surface (polyethylene
oxide [PEO]-like) that minimizes molecular interactions (Figure 1). Since
proteins and other biomolecules passively adsorb to surfaces primarily through
hydrophobic and ionic interactions, the NBS surface lacking these
characteristics naturally inhibits nonspecific immobilization via these forces.
Figure 1. PEO chains immobilized on polystyrene create the nonionic
hydrophilic NBS surface that minimizes molecular binding.
Results (Table 1) show the NBS surface has the ability to significantly
reduce (<2 ng/cm2) protein and nucleic acid binding to microplates,
while maintaining enzyme activity. The nonionic, hydrophilic NBS surface
is therefore well suited for enhancement of signal-to-noise in homogeneous
assays such as Scintillation Proximity Assay (SPA). NBS surfaces are
stable to aqueous biological fluids and biological reagents containing up to
20% isopropyl alcohol or DMSO or 10 M urea or 1% SDS, and over a pH range
(3-11).
Table 1. Comparison of protein and nucleic acid binding with various polymers
Binding in ng/cm2
125I-IgG
125I-BSA
125I-Insulin
32P-oligoDNA
32P-l phageDNA
Polystyrene (PS)
400
450
310
22
6
Polypropylene 380
380
440
370
3
<2
NBS on PS
<2.5
<2.5
5
<2
<2
Based on a Scintillation Proximity Assay (SPA) using 100 µL/well in 96 well
microplates. Contents were aspirated and washed 3 times with 200 µL/well of
PBS, pH 7.4.
NOTE: Most samples will be shipped upon the request standard UPS ground
service; however some products require additional qualification prior to the
request being fulfilled. For these items a Corning Life Sciences Account
Manager will contact you with additional information.